Among the overlap between our HLA-pGenes and Tier 1 targets were IL10, CD80/CD86 (targets of abatacept, used for the treatment of RA), and the well-known cancer tyrosine kinase MERTK (Supplementary Data 21). Here, IL10 is linked to rheumatoid arthritis.